The outlook revision reflects Baxter’s continued volatility in operations and Moody’s Investors Service’s expectation that liquidity will remain constrained.
Moody’s also affirmed Baxter’s “Baa2” rating, affecting $41.8 million of debt. The rating affirmation is based on Baxter’s solid market position but remains constrained by Baxter’s small size.
More articles on healthcare finance:
231 hospitals inadvertently earned Medicare bonuses despite lower quality care
Harvard study finds consumer price shopping doesn’t lower healthcare costs
Fitch: As acquisitions continue, healthcare leverage increases
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
